Viewing Study NCT02410694


Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2026-02-21 @ 12:13 AM
Study NCT ID: NCT02410694
Status: COMPLETED
Last Update Posted: 2019-12-13
First Post: 2015-02-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-04
Start Date Type: ACTUAL
Primary Completion Date: 2019-03-28
Primary Completion Date Type: ACTUAL
Completion Date: 2019-05-02
Completion Date Type: ACTUAL
First Submit Date: 2015-02-09
First Submit QC Date: None
Study First Post Date: 2015-04-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-12-12
Last Update Post Date: 2019-12-13
Last Update Post Date Type: ACTUAL